13F HOLDINGS REPORT
Kinnevik AB (publ)
Quarter ended Q2 2025 · Filed August 13, 2025 · Accession 0001415889-25-021634
Total Value
$68.0M
Positions
1
Other Managers
1
Confidential Omitted
No
Holdings (1)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Recursion Pharmaceuticals, Inc. | RXRX | 13,434,171 | $68.0M | 100.00% |